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Oral presentation; Theme: trace organic contaminants 
Conventional models, describing the xenobiotic organic micro-pollutant fate in 
sewage treatment can be limited in describing full-scale systems. This can, in part, 
be explained by the fact that these models have been identified and calibrated using 
data obtained in batch experiments spiked with reference substances. Xenobiotic 
parent compounds, however, can be formed from other sewage fractions, occurring 
in municipal sewage, i.e. from human conjugates, other commercial chemicals and 
from fractions sorbed onto hydrolysable particulate, dissolved and colloidal matter 
(DCM) – some of which are very difficult or impossible to detect (Plósz et al., 2010a). 
Additionally, besides neutral chemicals, contaminants, in particular pharmaceuticals 
can be acidic, basic, amphoteric or zwitterionic. Under different pH conditions, typical 
to WWTPs, their partitioning behaviour thus cannot be accounted for by a single 
sorption coefficient, KD (Plósz et al., 2010b). Furthermore, growth substrates can 
impact the cometabolic substrate oxidation process – a compound specific impact 
that should be accounted for in process models (Plósz et al., 2010b). The available 
terminal electron acceptors (e.g., oxygen, nitrate) and the metal salt (iron, aluminium) 
dosed for phosphorus removal can additionally influence contaminant removal (Plósz 
et al., 2010b). Thus a new framework of activated sludge modelling for xenobiotics 
(ASM-X) has been recently proposed (Plósz et al., 2010a,b). 
Here we present extensions for the ASM-X, and the process model developed 
predicts the removal of diclofenac and carbamazepine in an activated sludge system. 
In this outline paper, we only demonstrate our research work using concentration 
data obtained for diclofenac in the liquid phase (CLI) and in the solid phase (CSL) in 
the full-scale samples (Fig. 1). Batch experimental results, obtained using the micro-
pollutant content of pre-clarified municipal sewage, were used to identify the process 
model and to solve the inverse problem of estimating the biotransformation rate and 
half-saturation coefficient values, under anoxic and aerobic conditions (Fig. 1a). This 
method has originally been proposed by Plósz et al. (2010a). For model evaluation 
and confirmation, forward dynamic simulations were carried out using measured data 
obtained in a full-scale wastewater treatment plant, WWTP (Fig. 1b and Fig. 1c). For 
the forward simulations, eight-hour flow proportional samples, collected in 3 days 
under dry-weather conditions in the WWTP, were used (Plósz et al., 2010c). 
What is notable for the biotransformation of pollutants is that the combination of the 
measurement and simulation results suggest relatively high rate of contaminant 
biodegradation when the microbial growth is not limited by readily biodegradable 
substrates, SS, contained in the pre-clarified sewage – initial concentration in the 
batch experiments: 130 mg L-1 as COD (Fig. 1a). Approximation of the batch and full-
scale experimental results can effectively predict the contaminant removal using the 
model that accounts for the cometabolism of diclofenac and carbamazepine under 
different redox conditions. Experimental results obtained by Tran et al. (2009) using 
acetate as SS, confirms our findings, i.e. the diclofenac and carbamazepine 
biodegradation efficiencies, exhibited by heterotrophic bacteria, can be enhanced by 
increasing the initial growth substrate concentration. The separate biotransformation 
potential of heterotrophic organisms was assessed by Tran et al. (2009) via inhibiting 
the growth of nitrifiers in a reference experimental setup.  
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Figure 1 Values of diclofenac concentration measured (symbols) and simulated (solid and dashed line) 
in the aerobic and anoxic batch tests in the liquid phase, CLI (A-left); and diclofenac concentration 
measured (symbol) and simulated (solid and dashed line) in the pre-anoxic and aerobic effluent streams 
of the full-scale WWTP in the liquid phase (B-middle) and in the solid phase, CSL (C-right). The 
measured WWTP influent CLI concentration is shown with a square symbol (B-middle), and the 
concentration values used in the dynamic input time-series are shown with a thin black line. 
 
Model approximation of contaminant concentration, detected in the solid phase 
(Fig. 1c), suggest that only approximately 16% of the total solid diclofenac 
concentrations is due to sorption (1% for carbamazepine) – the remainder being non-
bioavailable and sequestered (SSL,I). Values of the solid-liquid partitioning coefficient 
(KD) used in this study are that shown by (Ternes and Joss, 2006). In the WWTP 
model, for the ionizing diclofenac, we estimated a separate KD value to account for 
the impact of pH, prevailing in the aerobic reactors. Our measured solid 
concentration data is in close agreement with the measured data presented by 
Radjenović et al. (2009). Taken together, we propose extending the ASM-X (Plósz et 
al., 2010) to account for (i) the impact of terminal electron donors and acceptors on 
biodegradation, (ii) the impact of pH, prevailing in anoxic and aerobic basins, on 
sorption and (iii) physical/chemical contaminant sequestration in solids. This research 
has particular relevance to model-based regional risk assessment and to decision 
support systems used in WWTP design and operation. 
 
References 
 
Plósz, B.G., Leknes, H., Thomas, K.V. (2010a) Impacts of competitive inhibition, parent compound 
formation and partitioning behaviour on antibiotic micro-pollutants removal in activated sludge. 
Environ. Sci. Technol. 44(2), 734–742. 
Plósz, B.G., Lehnberg, K., Dott, W., Thomas, K.V. (2010b) An activated sludge modelling framework for 
xenobiotic organic micro-pollutants (ASM-X) – factors influencing the biodegradation and sorption 
processes in WWTPs. Water Sci. Technol., WST-S-10-01716. 
Plósz, B.G., Leknes, H., Liltved, H., Thomas, K.V. (2010c) Diurnal variations in the occurrence and the 
fate of hormones and antibiotics in activated sludge wastewater treatment in Oslo, Norway. Sci. 
Total Environ. 408(8), 1915–1924. 
Radjenović, J., Petrović, M., Barceló, D. (2009) Fate and distribution of pharmaceuticals in wastewater 
and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor 
(MBR) treatment. Water Res. 43(3), 831–841. 
Ternes, T.A., Joss, A. (2006) Human pharmaceuticals, hormones and fragrances–The challenge of 
micropollutants in urban water management. IWA Publishing, London. 
Tran, N.H., Urase, T., Kusakabe, O. (2009) The characteristics of enriched nitrifier culture in the 
degradation of selected pharmaceutically active compounds. J. Haz. Mater. 171(1-3), 1051–1057. 
